Literature DB >> 12665084

Cognitive-behavioral therapy plus contingency management for cocaine use: findings during treatment and across 12-month follow-up.

David H Epstein1, Wesley E Hawkins, Lino Covi, Annie Umbricht, Kenzie L Preston.   

Abstract

Contingency management (CM) rapidly reduces cocaine use, but its effects subside after treatment. Cognitive-behavioral therapy (CBT) produces reductions months after treatment. Combined, the 2 might be complementary. One hundred ninety-three cocaine-using methadone-maintained outpatients were randomly assigned to 12 weeks of group therapy (CBT or a control condition) and voucher availability (CM contingent on cocaine-negative urine or noncontingent). Follow-ups occurred 3, 6, and 12 months posttreatment. Primary outcome was cocaine-negative urine (urinalysis 3 times/week during treatment and once at each follow-up). During treatment, initial effects of CM were dampened by CBT. Posttreatment, there were signs of additive benefits, significant in 3- versus 12-month contrasts. Former CBT participants were also more likely to acknowledge cocaine use and its effects and to report employment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12665084      PMCID: PMC1224747          DOI: 10.1037/0893-164x.17.1.73

Source DB:  PubMed          Journal:  Psychol Addict Behav        ISSN: 0893-164X


  24 in total

1.  Competing motivations: drug reinforcement vs non-drug reinforcement.

Authors:  G E Bigelow; R K Brooner; K Silverman
Journal:  J Psychopharmacol       Date:  1998       Impact factor: 4.153

2.  Comparison of population-averaged and subject-specific approaches for analyzing repeated binary outcomes.

Authors:  F B Hu; J Goldberg; D Hedeker; B R Flay; M A Pentz
Journal:  Am J Epidemiol       Date:  1998-04-01       Impact factor: 4.897

3.  Measurement properties of quantitative urine benzoylecgonine in clinical trials research.

Authors:  K L Delucchi; R T Jones; S L Batki
Journal:  Addiction       Date:  1997-03       Impact factor: 6.526

4.  Effects of chronic cocaine use on physical health: a prospective study in a general population sample.

Authors:  K Chen; L M Scheier; D B Kandel
Journal:  Drug Alcohol Depend       Date:  1996-12-02       Impact factor: 4.492

5.  Now you see it, now you don't: a comparison of traditional versus random-effects regression models in the analysis of longitudinal follow-up data from a clinical trial.

Authors:  C Nich; K Carroll
Journal:  J Consult Clin Psychol       Date:  1997-04

Review 6.  The influence of alternative reinforcers on cocaine use and abuse: a brief review.

Authors:  S T Higgins
Journal:  Pharmacol Biochem Behav       Date:  1997-07       Impact factor: 3.533

7.  Contingent reinforcement increases cocaine abstinence during outpatient treatment and 1 year of follow-up.

Authors:  S T Higgins; C J Wong; G J Badger; D E Ogden; R L Dantona
Journal:  J Consult Clin Psychol       Date:  2000-02

8.  The brief abstinence test: voucher-based reinforcement of cocaine abstinence.

Authors:  E Robles; K Silverman; K L Preston; E J Cone; E Katz; G E Bigelow; M L Stitzer
Journal:  Drug Alcohol Depend       Date:  2000-02-01       Impact factor: 4.492

9.  Methadone dose increase and abstinence reinforcement for treatment of continued heroin use during methadone maintenance.

Authors:  K L Preston; A Umbricht; D H Epstein
Journal:  Arch Gen Psychiatry       Date:  2000-04

10.  Broad beneficial effects of cocaine abstinence reinforcement among methadone patients.

Authors:  K Silverman; C J Wong; A Umbricht-Schneiter; I D Montoya; C R Schuster; K L Preston
Journal:  J Consult Clin Psychol       Date:  1998-10
View more
  58 in total

1.  Exploring the limits and utility of operant conditioning in the treatment of drug addiction.

Authors:  Kenneth Silverman
Journal:  Behav Anal       Date:  2004

2.  A randomized trial of culturally accommodated versus standard group treatment for Latina/o adolescents with substance use disorders: Posttreatment through 12-month outcomes.

Authors:  Jason J Burrow-Sánchez; Hyman Hops
Journal:  Cultur Divers Ethnic Minor Psychol       Date:  2018-12-03

3.  Comparing adaptive stepped care and monetary-based voucher interventions for opioid dependence.

Authors:  Robert K Brooner; Michael S Kidorf; Van L King; Kenneth B Stoller; Karin J Neufeld; Ken Kolodner
Journal:  Drug Alcohol Depend       Date:  2007-01-24       Impact factor: 4.492

Review 4.  Contingency management interventions for HIV-related behaviors.

Authors:  Nancy A Haug; James L Sorensen
Journal:  Curr HIV/AIDS Rep       Date:  2006-11       Impact factor: 5.071

5.  Abstinence rates following behavioral treatments for marijuana dependence.

Authors:  Ronald M Kadden; Mark D Litt; Elise Kabela-Cormier; Nancy M Petry
Journal:  Addict Behav       Date:  2006-09-22       Impact factor: 3.913

6.  Randomized trial of prize-based reinforcement density for simultaneous abstinence from cocaine and heroin.

Authors:  Udi E Ghitza; David H Epstein; John Schmittner; Massoud Vahabzadeh; Jia-Ling Lin; Kenzie L Preston
Journal:  J Consult Clin Psychol       Date:  2007-10

7.  Effect of reinforcement probability and prize size on cocaine and heroin abstinence in prize-based contingency management.

Authors:  Udi E Ghitza; David H Epstein; John Schmittner; Massoud Vahabzadeh; Jia-Ling Lin; Kenzie L Preston
Journal:  J Appl Behav Anal       Date:  2008

8.  Behavioral treatment for marijuana dependence: randomized trial of contingency management and self-efficacy enhancement.

Authors:  Mark D Litt; Ronald M Kadden; Nancy M Petry
Journal:  Addict Behav       Date:  2012-08-31       Impact factor: 3.913

9.  Cocaine craving and use during daily life.

Authors:  Kenzie L Preston; Massoud Vahabzadeh; John Schmittner; Jia-Ling Lin; David A Gorelick; David H Epstein
Journal:  Psychopharmacology (Berl)       Date:  2009-09-24       Impact factor: 4.530

10.  Cognitive-behavioral treatment with adult alcohol and illicit drug users: a meta-analysis of randomized controlled trials.

Authors:  Molly Magill; Lara A Ray
Journal:  J Stud Alcohol Drugs       Date:  2009-07       Impact factor: 2.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.